The Analysis Of Enterprise Strategy Base On The Competition Against Model

In the context of globalization, the development of domestic enterprises inevitably be incorporated into competition in the world market, the domestic and global markets combined. After 80 years of reform and opening up, along with China’s economic takeoff, an increasing number of large well-known multinational pharmaceutical companies to enter and occupy the Chinese market. Especially in the 21 st century, the multinational pharmaceutical giants have set foot in China to accelerate the research and development, production and R & D centers have been set up in the country. China, as the world’s few large countries demographic dividend, any one multinational pharmaceutical companies attach great importance can not be underestimated. With the "silver" wave hit, our advance into the aging society, the demand for drugs continued to improve; the face of such a huge market space, multinational pharmaceutical companies through a variety of ways to expand market share in China, the Chinese market is already become an important source of profits.In the fierce market competition at home and abroad in the dual, China’s domestic pharmaceutical companies how to face the fierce market challenges, seeking to survive and grow in the cracks; how to enhance their own strength, increase the competitiveness of the industry, a place in the market. These issues are all pharmaceutical business owners have to face and think of an important proposition. On the one hand, multinational pharmaceutical companies to invest in the construction of factories in China, set up R & D center, to carry out clinical trials, so that Chinese companies have the opportunity to learn more advanced pharmaceutical technology and processes, and enhance the vitality of domestic enterprises, while promoting economic development; the other respect, multinational pharmaceutical companies on brand name drugs in the pharmaceutical market occupies a dominant position, grab the high profits, and local enterprises to compete while eating the domestic pharmaceutical market this huge cake; this same time, multinational pharmaceutical companies are often able to rely its own advantages, advanced management concepts and generous salaries and other remuneration, will attract the best talent to the pharmaceutical firm.This paper analyzes the literature and case studies from many aspects of comparative gap between domestic pharmaceutical companies and multinational pharmaceutical firms. Select two of the most representative companies to establish and compete against competitors analytical framework model to analyze the behavior of both the competition and concluded that the strategic choice to provide suggestions for the development of China’s pharmaceutical enterprises.Chapter1 is introduction section describes the background, significance; research methods and innovations;Chapter2 is introduction and narrative by choosing a representative of the company and the basic situation of multinational pharmaceutical companies as well as our local pharmaceutical companies, the development of a dynamic and elaborate a brief introduction;Chapter3 is research the two companies compete with confrontational representative in many aspectsChapter4 is analyze by competitor analysis framework, set up rivalry model;Chapter5 is suggestions and countermeasures according to the research by Strategic business decisions.